Industry News

FDA Approves Orphan Drug Designation for Pharmaceutical Cannabidiol
RedHill Biopharma Acquires Phase II Oncology Drug MESUPRON(R) From WILEX AG
Flamel Technologies Announces FDA Approval of VAZCULEP
RedHill Biopharma Acquires Phase II Oncology Drug MESUPRON(R) From WILEX AG
Prescriptions Plus Inc Now Offering Prescription Topical Pain Creams for Migraine Headache Relief Nationwide
AJMC Review of Specialty Pharmaceuticals Finds New Drugs Prove Their Value
Bristol-Myers Squibb Issues Voluntary Nationwide Recall of Coumadin (Warfarin Sodium) for Injection Due to Presence of Particulate Matter
Actavis Completes Acquisition of Furiex Pharmaceuticals
Leaving: Two companies pulling workforce out of Jersey
Prescriptions Plus Inc Now Offering Prescription Topical Pain Creams for Migraine Headache Relief Nationwide
NutriGold's Fish Oil Supplement IFOS 5-star Certified and ConsumerLab Approved
Argo receives FDA approval for walk rehabilitation device
Inhaled insulin Afrezza approved by FDA
French drug maker takes stake in UAE pharma firm
Breakthrough study sheds new light on best medication for children with seizures Clinical Trials and Studies
Janssen Submits EU Marketing Application for VELCADE� (bortezomib) in Mantle Cell Lymphoma
EYLEA Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
CHPA Response to FDA Consumer Communication on Teething Pain Treatments
Fortune Oil & Gas' Manzo Pharmaceuticals Introduces Tummy Relief for Babies
Evofem Announces the Completion of the Largest Phase III Contraceptive Clinical Trial to Date.
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before
Evofem Announces the Completion of the Largest Phase III Contraceptive Clinical Trial to Date.
Fortune Oil & Gas' Manzo Pharmaceuticals Introduces Tummy Relief for Babies
Actavis invests 13 million in new warehouse facilities
Actavis invests �13 million in new warehouse facilities